Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy.

Arrowsmith, J B; Gerstman, B B; Fleischer, D E; Benjamin, S B

Arrowsmith, J B; Gerstman, B B; Fleischer, D E; Benjamin, S B.

Affiliation

Arrowsmith JB; U.S. Food and Drug Administration, Rockville, MD.

Gastrointest Endosc ; 37(4): 421-7, 1991.

Article in En | MEDLINE | ID: mdl-1833259

Subject(s)

Diazepam/adverse effects; Endoscopy, Gastrointestinal/adverse effects; Midazolam/adverse effects; Aged; Cholangiopancreatography, Endoscopic Retrograde/adverse effects; Conscious Sedation/adverse effects; Diazepam/administration & dosage; Female; Heart Diseases/chemically induced; Heart Diseases/etiology; Humans; Injections, Intravenous; Laparoscopy/adverse effects; Male; Midazolam/administration & dosage; Middle Aged; Respiration Disorders/chemically induced; Respiration Disorders/etiology; Retrospective Studies

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Midazolam / Endoscopy, Gastrointestinal / Diazepam Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 1991 Type: Article

Search on Google

XML

PubMed Links